Helius medical technologies.

Helios Technologies, Inc. (NYSE:HLIO) Q3 2023 Earnings Call Transcript November 3, 2023 Operator: Greetings and welcome to the Helios Technologies Third Quarter 2023 Financial Results Conference Call.Helius Medical Technologies, Inc. (NASDAQ:HSDT) announced its earnings results on Thursday, November, 9th. The company reported ($5.49) EPS for the quarter. The firm earned $0.14 million during the quarter. Helius Medical Technologies had a negative net margin of 1,602.40% and a negative trailing twelve-month return on equity of 232.74%.Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company’s product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short …Contact Helius Our Headquarters642 Newtown Yardley Rd., Ste 100Newtown, PA 18940Phone: +1 877-564-0008 The Portable Neuromodulation Stimulator (PoNS®) is an authorized medical device in the US. The PoNS device is indicated for use as a short-term treatment of gait deficit due to mild to moderate symptoms from multiple sclerosis (MS) and is to be usedHelius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...

Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability ...Helius brings together the world’s best talent to succeed in our ongoing mission. Together, we work passionately to develop and deliver easy-to-use technology for neurological wellness. If you want to join us in our mission, we want to hear from you. Email your letter of interest and resume to [email protected].

Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability to compensate and promotes neuroplasticity, aiming to improve the lives of people dealing with neurologic diseases. The Company’s …

Track Helius Medical Technologies Inc (HSDT) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsHelius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...Apr 26, 2022 · Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ... Dec 1, 2023 · Helius Medical Technologies, Inc. to Release Third Quarter 2023 Financial Results on November 9, 2023; Announces Extended Cash Runway into Q2 2024. GlobeNewswire Nov 2, 2023 9:05pm. Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...

We would like to show you a description here but the site won’t allow us.

Helius Medical Technologies (NASDAQ: NASDAQ:HSDT) is a tiny microcap with a $14.51m market capitalization that $100m in volume has transacted through in the past month.

Earnings for Helius Medical Technologies are expected to grow in the coming year, from ($8.73) to ($6.26) per share. Helius Medical Technologies has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 14th, 2024 based off prior year's report dates. Read More.Exhibit 10.1. AMENDMENT 2. TO. HELIUS MEDICAL TECHNOLOGIES, INC. 2018 OMNIBUS INCENTIVE PLAN RECITALS A.Helius Medical Technologies, Inc., a Delaware corporation (the “Company”) sponsors the Helius Medical Technologies, Inc. 2018 Omnibus Incentive Plan (as previously amended by Amendment No. 1, the “Plan”). …Helius Medical Technologies is a neurotech company focused on neurological wellness. The Company’s purpose is to develop, license and acquire unique and non-invasive platform technologies that ...Helius Medical Technologies, Inc. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain's ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the development of the …Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...Helius Medical Technologies is a neurotech company focused on neurological wellness. The Company’s purpose is to develop, license and acquire unique and non-invasive platform technologies that ...Helius Medical Technologies, Inc. to Release Third Quarter 2023 Financial Results on November 9, 2023; Announces Extended Cash Runway into Q2 2024. -- Expects to report Q3 revenues in range of $140 - $150 thousand, reflecting the expected decrease in U.S. sales with the conclusion of the Patient Therapy Access Program (PTAP) on June 30, 2023

Aug 5, 2022 · Helius Medical Technologies is a neurotech company focused on neurological wellness. The Company’s purpose is to develop, license and acquire unique and non-invasive platform technologies that ... THE UNDERSIGNED DOES HEREBY CERTIFY, on behalf of Helius Medical Technologies, Inc., a Delaware corporation (the “Company”), that the following resolution was duly adopted by the board of directors of the Corporation (the “Board”), in accordance with the provisions of Section 151 of the General Corporation Law of the State of …DELAWARE. 001-38445. 36-4787690 (State or Other Jurisdiction. of Incorporation) (Commission File Number) (IRS Employer. Identification No.) 642 Newtown Yardley Road, Suite 100. Newtown, PA. 18940Nov 2, 2023 · Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability ... In today’s digital age, technology has revolutionized many aspects of our lives, including the healthcare industry. One significant advancement is the availability of online medical charts, which have transformed the way healthcare provider...

Do you have unused medical equipment lying around your house? Are you looking for a way to donate it to those in need? If so, this guide is for you. Here, we’ll discuss where to donate your unused medical equipment and how to do it.

Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology …Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using an orally applied technology platform that amplifies the brain’s ...Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability ...Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...Sep 28, 2023 · Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability ... In today’s fast-paced world, technology has become an integral part of our lives. From ordering food to booking a cab, everything can be done with just a few clicks on our smartphones. In the medical field, technology has revolutionized pat...Helius Medical Technologies, Inc. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform ...Bausch + Lomb Corp. 15.64. -0.04. -0.26%. Get Helius Medical Technologies Inc (HSDT:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.Aug 5, 2022 · Helius Medical Technologies is a neurotech company focused on neurological wellness. The Company’s purpose is to develop, license and acquire unique and non-invasive platform technologies that ... Exhibit 10.1. Employment Agreement . THIS EMPLOYMENT AGREEMENT (this “Agreement”) by and between Helius Medical Technologies, Inc., a Delaware corporation (the “Company”), and Dane C. Andreeff (the “Executive”) is entered into by the Company and the Executive and made effective as of June 14, 2021 (the “Effective Date”).. Recitals …

About Helius Medical Technologies, Inc. Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability to compensate and promote neuroplasticity, improving the lives of people dealing with neurologic diseases.

Our next medical device stock short idea is Helius Medical Technologies (NASDAQ:HSDT). It is a pre-revenue, $200M+ market cap company claiming its only product, the Portable Neuromodulation ...

Jan 23, 2023 · Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ... Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability ...About Helius Medical Technologies, Inc. Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms and promote neuroplasticity, improving the lives of people ...Helius Medical Technologies has extended by six months a program that allows multiple sclerosis (MS) patients in the U.S. to access its Portable Neuromodulation Stimulator (PoNS) device at a ...DELAWARE. 001-38445. 36-4787690 (State or Other Jurisdiction. of Incorporation) (Commission File Number) (IRS Employer. Identification No.) 642 Newtown Yardley Road, Suite 100Exhibit 10.2. Employment Agreement . THIS EMPLOYMENT AGREEMENT (this “Agreement”) by and between Helius Medical Technologies, Inc., a Delaware corporation (the “Company”), and Jeffrey S. Mathiesen (the “Executive”) is entered into by the Company and the Executive and made effective as of June 14, 2021 (the “Effective Date”).. Recitals ...Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...As previously disclosed, the employment of Joyce LaViscount, Chief Operating Officer of Helius Medical Technologies, Inc. (the “Company”) ended on July 20, 2021 (the “Separation Date”). In connection with Ms. LaViscount’s notice of intent to resign for “Good Reason” under her employment agreement dated October 19, 2015, as …

Mar 23, 2023 · Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ... Nov 24, 2023 · Helius Medical Technologies, Inc. (NASDAQ:HSDT) announced its earnings results on Thursday, November, 9th. The company reported ($5.49) EPS for the quarter. The firm earned $0.14 million during the quarter. Helius Medical Technologies had a negative net margin of 1,602.40% and a negative trailing twelve-month return on equity of 232.74%. Helius Medical Technologies has extended by six months a program that allows multiple sclerosis (MS) patients in the U.S. to access its Portable Neuromodulation Stimulator (PoNS) device at a ...Instagram:https://instagram. good brokers for day tradingbest forex trading appsbest forex broker for mt4cobalt metal etf About Helius Medical Technologies, Inc. Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability to compensate and promotes neuroplasticity, aiming to improve the lives of people dealing with neurologic ...On February 16, 2020, Mr. Thomas Griffin notified the Board of Directors (the “Board”) of Helius Medical Technologies, Inc. (the “Company”) of his intent not to run for reelection at the Company’s 2020 annual meeting of stockholders (the “Annual Meeting”). His term as director of the Company will conclude at the Annual Meeting. Mr. artificial intelligence stockgold brokerage Dec 1, 2023 · A high-level overview of Helius Medical Technologies, Inc. (HSDT) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Sep 21, 2023 · About Helius Medical Technologies, Inc. Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability to compensate and promote neuroplasticity, improving the lives of people dealing with neurologic diseases. j. m. smucker co. Helius Medical Technologies, In. Daily – Vickers Top Insider Picks for 11/30/2023 The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies ...Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability ...